留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

成人慢性癌症相关性疼痛治疗与管理

余佳文 王瑾 刘红菊 许力 宁晓红 黄宇光

余佳文, 王瑾, 刘红菊, 许力, 宁晓红, 黄宇光. 成人慢性癌症相关性疼痛治疗与管理[J]. 协和医学杂志. doi: 10.12290/xhyxzz.2024-0003
引用本文: 余佳文, 王瑾, 刘红菊, 许力, 宁晓红, 黄宇光. 成人慢性癌症相关性疼痛治疗与管理[J]. 协和医学杂志. doi: 10.12290/xhyxzz.2024-0003
YU Jiawen, WANG Jin, LIU Hongju, XU Li, NING Xiaohong, HUANG Yuguang. Treatment and Management of Chronic Cancer-related Pain in Adults[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2024-0003
Citation: YU Jiawen, WANG Jin, LIU Hongju, XU Li, NING Xiaohong, HUANG Yuguang. Treatment and Management of Chronic Cancer-related Pain in Adults[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2024-0003

成人慢性癌症相关性疼痛治疗与管理

doi: 10.12290/xhyxzz.2024-0003
详细信息
    通讯作者:

    刘红菊,E-mail:liuhongju@pumch.cn

  • 中图分类号: R614; R73

Treatment and Management of Chronic Cancer-related Pain in Adults

  • 摘要: 疼痛是癌症患者最常见的症状之一, 其除可引起患者不愉快的感觉和情绪体验外, 还可能影响患者的整体功能及生活质量、与不良预后相关。慢性癌症相关性疼痛控制不佳可能与其复杂的疼痛机制、现有临床治疗手段的局限性以及医患认知不足有关。本文总结慢性癌症相关性疼痛的定义、分类、评估要点、治疗原则、药物及非药物治疗手段及相关临床更新, 同时强调多学科综合管理、患者及家属宣教在癌痛管理中的重要性, 以期为临床医生提供成人癌症患者疼痛管理的整体思路。
  • [1] SNIJDERS R, BROM L, THEUNISSEN M, et al. Update on Prevalence of Pain in Patients with Cancer 2022:A Systematic Literature Review and Meta-Analysis[J]. Cancers, 2023, 15(3).
    [2] SHAH K, GELLER D A, TOHME S, et al. Predictors and Consequences of Cancer and Non-CancerRelated Pain in Those Diagnosed with Primary and Metastatic Cancers[J]. Curr Oncol, 2023, 30(10):8826-40.
    [3] MANTYH P W. Cancer pain and its impact on diagnosis, survival and quality of life[J]. Nature Reviews Neuroscience, 2006, 7(10):797-809.
    [4] JANJAN N. Improving cancer pain control with NCCN guideline-based analgesic administration:a patient-centered outcome[J]. Journal of the National Comprehensive Cancer Network:JNCCN, 2014, 12(9):1243-9.
    [5] BENNETT M I, KAASA S, BARKE A, et al. The IASP classification of chronic pain for ICD-11:chronic cancer-related pain[J]. Pain, 2019, 160(1):38-44.
    [6] 李小梅, 袁文茜, 曹伯旭, et al. 慢性癌症相关性疼痛[J]. 中国疼痛医学杂志, 2021, 27(03):161-5.
    [7] GOULD ROTHBERG B E, QUEST T E, YEUNG S C J, et al. Oncologic emergencies and urgencies:A comprehensive review[J]. CA:A Cancer Journal for Clinicians, 2022, 72(6):570-93.
    [8] NETWORK N C C. Adult Cancer Pain, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology[Z]. 2023
    [9] FAINSINGER R L, NEKOLAICHUK C L. A "TNM" classification system for cancer pain:The Edmonton Classification System for Cancer Pain (ECS-CP)[J]. Supportive Care in Cancer, 2008, 16(6):547-55.
    [10] TANCO K, ARTHUR J, HAIDER A, et al. The impact of a simplified documentation method for the Edmonton classification system for cancer pain (ECS-CP) on clinician utilization[J]. Supportive Care In Cancer:Official Journal of the Multinational Association of Supportive Care In Cancer, 2017, 25(2):575-80.
    [11] HWANG S S, CHANG V T, FAIRCLOUGH D L, et al. Development of a cancer pain prognostic scale[J]. Journal of Pain and Symptom Management, 2002, 24(4):366-78.
    [12] ORGANIZATION W H. Cancer Pain Relief[Z]. 1986
    [13] WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents[M]. WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents. Geneva; World Health Organization © World Health Organization 2018. 2018.
    [14] SCARBOROUGH B M, SMITH C B. Optimal pain management for patients with cancer in the modern era[J]. CA:A Cancer Journal for Clinicians, 2018, 68(3):182-96.
    [15] LAU J, FLAMER D, MURPHY-KANE P. Interventional anesthesia and palliative care collaboration to manage cancer pain:a narrative review[J]. Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2019, 67(2):235-46.
    [16] HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics[Z]. 2019
    [17] CORLI O, FLORIANI I, ROBERTO A, et al. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids[J]. Annals of Oncology:Official Journal of the European Society For Medical Oncology, 2016, 27(6):1107-15.
    [18] QUIGLEY C. Opioids in people with cancer-related pain[J]. BMJ Clin Evid, 2008, 2008.
    [19] WIFFEN P J, WEE B, DERRY S, et al. Opioids for cancer pain-an overview of Cochrane reviews[J]. Cochrane Database Syst Rev, 2017, 7(7):CD012592.
    [20] WIFFEN P J, WEE B, MOORE R A. Oral morphine for cancer pain[J]. The Cochrane Database of Systematic Reviews, 2016, 4(4):CD003868.
    [21] 中国临床肿瘤学会肿瘤支持与康复治疗专家委员会, 中国抗癌协会肿瘤康复与姑息治疗专家委员会, 中华医学会麻醉学分会, et al. 癌痛管理中疼痛危象理念的形成与管理方案专家建议[J]. 中华医学杂志, 2023, 103(21):1591-5.
    [22] SCHUSTER M, BAYER O, HEID F, et al. Opioid Rotation in Cancer Pain Treatment[J]. Dtsch Arztebl Int, 2018, 115(9):135-42.
    [23] YAN P Z, BUTLER P M, KUROWSKI D, et al. Beyond neuropathic pain:gabapentin use in cancer pain and perioperative pain[J]. Clin J Pain, 2014, 30(7):613-29.
    [24] GüL Ş K, TEPETAM H, GüL H L. Duloxetine and pregabalin in neuropathic pain of lung cancer patients[J]. Brain Behav, 2020, 10(3):e01527.
    [25] CHANDLER III G, ROJAS A M, WORTS P R, et al. Utilizing Multidisciplinary Medicine in Pain Management:A Narrative Review[J]. Pain Physician, 2021, 24(5):369-78.
    [26] BATES D, SCHULTHEIS B C, HANES M C, et al. A Comprehensive Algorithm for Management of Neuropathic Pain[J]. Pain Med, 2019, 20(Suppl 1).
    [27] PRITCHARD K T, BAILLARGEON J, LEE W-C, et al. Trends in the Use of Opioids vs Nonpharmacologic Treatments in Adults With Pain, 2011-2019[J]. JAMA Network Open, 2022, 5(11):e2240612.
    [28] CHEVILLE A L, BASFORD J R. Role of Rehabilitation Medicine and Physical Agents in the Treatment of Cancer-Associated Pain[J]. Journal of Clinical Oncology, 2014, 32(16):1691-702.
    [29] MAO J J, LIOU K T, BASER R E, et al. Effectiveness of Electroacupuncture or Auricular Oncology, 2021, 7(5).
    [30] COHEN S P, VASE L, HOOTEN W M. Chronic pain:an update on burden, best practices, and new advances[J]. The Lancet, 2021, 397(10289):2082-97.
    [31] LIU W C, ZHENG Z X, TAN K H, et al. Multidimensional Treatment of Cancer Pain[J]. Current Oncology Reports, 2017, 19(2).
    [32] VAYNE-BOSSERT P, AFSHARIMANI B, GOOD P, et al. Interventional options for the management of refractory cancer pain——what is the evidence?[J]. Support Care Cancer, 2016, 24(3):1429-38.
    [33] NIJLAND L, SCHMIDT P, FROSCH M, et al. Subcutaneous or intravenous opioid administration by patient-controlled analgesia in cancer pain:a systematic literature review[J]. Support Care Cancer, 2019, 27(1):33-42.
    [34] 冯智英, 王昆, 金毅, et al. 鞘内药物输注技术用于癌痛管理的中国专家共识(2022版)[J]. 中华疼痛学杂志, 2022, 18(5):11.
    [35] PEREZ J, OLIVIER S, RAMPAKAKIS E, et al. The McGill University Health Centre Cancer Pain Clinic:A Retrospective Analysis of an Interdisciplinary Approach to Cancer Pain Management[J]. Pain Research and Management, 2016, 2016:1-7.
    [36] PAICE J A, PORTENOY R, LACCHETTI C, et al. Management of Chronic Pain in Survivors of Adult Cancers:American Society of Clinical Oncology Clinical Practice Guideline[J]. Journal of Clinical Oncology:Official Journal of the American Society of Clinical Oncology, 2016, 34(27):3325-45.
    [37] FALLON M, GIUSTI R, AIELLI F, et al. Management of cancer pain in adult patients:ESMO Clinical Practice Guidelines[J]. Annals of Oncology, 2018, 29:iv166-iv91.
    [38] NAHIN R L. Use of Multimodal Multidisciplinary Pain Management in the US[J]. JAMA Network Open, 2022, 5(11):e2240620.
    [39] 郑晖;王亚龙. 重视癌痛综合管理, 全面提升癌痛诊治水平[J]. 中华医学杂志, 2024, 3(104):167- 70.
    [40] SU C, CHEN M, CHEN G, et al. Practices and Hindrances in Cancer Pain Management:Results of a National Multi-Cancer Center Survey Among Healthcare Professionals in China[J]. Cancer Manag Res, 2021, 13:1709-17.
    [41] HOCHBERG U, PEREZ J, BOROD M. New frontier:cancer pain management clinical fellowship[J]. Supportive Care in Cancer, 2018, 26(7):2453-7.
    [42] BUTLER S H, LOESER J D. Multidisciplinary Pain Management:A Tale of Two Outcomes[J]. Anesthesiology, 2023, 138(3):312-5.
    [43] SHRESTHA S, KC B, BLEBIL A Q, et al. Pharmacist Involvement in Cancer Pain Management:A Systematic Review and Meta-Analysis[J]. J Pain, 2022, 23(7):1123-42.
    [44] MEHTA A, CHAN L S. Understanding of the Concept of "Total Pain":A Prerequisite for Pain Control[J]. Journal of Hospice & Palliative Nursing, 2008, 10(1):26-32.
    [45] MYRCIK D, STATOWSKI W, TRZEPIZUR M, et al. Influence of Physical Activity on Pain, Depression and Quality of Life of Patients in Palliative Care:A Proof-of-Concept Study[J]. J Clin Med, 2021, 10(5).
    [46] ARANTZAMENDI M, BELAR A, PAYNE S, et al. Clinical Aspects of Palliative Sedation in Prospective Studies. A Systematic Review[J]. Journal of Pain and Symptom Management, 2021, 61(4).
    [47] CHERNY N I. ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation†[J]. Annals of Oncology, 2014, 25:iii143-iii52.
    [48] LOVELL M R, LUCKETT T, BOYLE F M, et al. Patient education, coaching, and self-management for cancer pain[J]. Journal of Clinical Oncology:Official Journal of the American Society of Clinical Oncology, 2014, 32(16):1712-20.
    [49] MARIE N, LUCKETT T, DAVIDSON P M, et al. Optimal patient education for cancer pain:a systematic review and theory-based meta-analysis[J]. Supportive Care In Cancer:Official Journal of the Multinational Association of Supportive Care In Cancer, 2013, 21(12):3529-37.
    [50] PAICE J A, BOHLKE K, BARTON D, et al. Use of Opioids for Adults With Pain From Cancer or Cancer Treatment:ASCO Guideline[J]. Journal of Clinical Oncology:Official Journal of the American Society of Clinical Oncology, 2023, 41(4):914-30.
  • 加载中
计量
  • 文章访问数:  55
  • HTML全文浏览量:  7
  • PDF下载量:  5
  • 被引次数: 0
出版历程
  • 网络出版日期:  2024-04-11

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!